BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19916743)

  • 1. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
    Sharma A; Ray R; Rajeswari MR
    Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
    Zou Y; Wang Y
    J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.
    Baldassarre G; Belletti B; Battista S; Nicoloso MS; Pentimalli F; Fedele M; Croce CM; Fusco A
    Oncogene; 2005 Oct; 24(45):6809-19. PubMed ID: 16007157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
    Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
    Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin.
    Sharma A; Ramanjaneyulu A; Ray R; Rajeswari MR
    DNA Cell Biol; 2009 Jul; 28(7):311-8. PubMed ID: 19435426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
    Huso TH; Resar LM
    Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A.
    Adair JE; Maloney SC; Dement GA; Wertzler KJ; Smerdon MJ; Reeves R
    Cancer Res; 2007 Jul; 67(13):6044-52. PubMed ID: 17616660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
    Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
    Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin-induced apoptosis in laryngeal squamous cell carcinoma strain and the influence on cell cycle].
    Qi F; Zhang B; Xu Y
    Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):298-301. PubMed ID: 11601059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of microRNA expression by HMGA1 proteins.
    De Martino I; Visone R; Fedele M; Petrocca F; Palmieri D; Martinez Hoyos J; Forzati F; Croce CM; Fusco A
    Oncogene; 2009 Mar; 28(11):1432-42. PubMed ID: 19169275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
    Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
    Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
    Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
    Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The canine HMGA1.
    Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Flohr AM; Nolte I; Bullerdiek J
    Gene; 2004 Apr; 330():93-9. PubMed ID: 15087128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma.
    Gupta V; Agrawal RC; Trivedi P
    Acta Pharm; 2011 Mar; 61(1):63-71. PubMed ID: 21406344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.